HEALTH TECHNOLOGY ASSESSMENT

Scope & Guideline

Navigating the complexities of health technology for better outcomes.

Introduction

Explore the comprehensive scope of HEALTH TECHNOLOGY ASSESSMENT through our detailed guidelines, including its aims and scope. Stay updated with trending and emerging topics, and delve into declining areas to understand shifts in academic interest. Our guidelines also showcase highly cited topics, featuring influential research making a significant impact. Additionally, discover the latest published papers and those with high citation counts, offering a snapshot of current scholarly conversations. Use these guidelines to explore HEALTH TECHNOLOGY ASSESSMENT in depth and align your research initiatives with current academic trends.
LanguageEnglish
ISSN1366-5278
PublisherNIHR JOURNALS LIBRARY
Support Open AccessYes
CountryUnited Kingdom
TypeJournal
Convergefrom 1994 to 2024
AbbreviationHEALTH TECHNOL ASSES / Health Technol. Assess.
Frequency-
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
AddressUNIV SOUTHAMPTON, EVALUATION, TRIALS & STUDIES COORDINATING CENTRE, ALPHA HOUSE, ENTERPRISE RD, SOUTHAMPTON SO16 7NS, ENGLAND

Aims and Scopes

The journal 'Health Technology Assessment' focuses on the rigorous evaluation of health technologies, encompassing clinical and economic assessments that inform decision-making in healthcare. It aims to provide comprehensive insights into the effectiveness, cost-effectiveness, and broader impact of health interventions.
  1. Clinical Effectiveness Assessments:
    The journal emphasizes the evaluation of clinical outcomes associated with various health technologies through randomized controlled trials (RCTs) and systematic reviews.
  2. Economic Evaluations:
    A significant focus is placed on economic analyses, including cost-effectiveness studies and health economic modeling, to assess the value of health interventions within healthcare systems.
  3. Mixed-Methods Research:
    Incorporation of qualitative methods alongside quantitative RCTs to understand patient experiences, preferences, and the contextual factors influencing health technology implementation.
  4. Real-World Evidence:
    The journal publishes studies that explore the effectiveness of health technologies in real-world settings, moving beyond controlled clinical trials to assess practical applicability.
  5. Intervention Development and Feasibility Studies:
    It includes research on the development, implementation, and feasibility of complex interventions, ensuring they are tailored to specific populations and contexts.
The landscape of health technology assessment is continuously evolving, with emerging themes reflecting contemporary healthcare challenges and innovations. This section outlines the trending areas within the journal.
  1. Digital Health Interventions:
    There is a significant increase in studies evaluating digital health technologies, such as telemedicine and mobile health applications, reflecting the growing integration of technology in patient care.
  2. Artificial Intelligence in Healthcare:
    Research focusing on the application of artificial intelligence for diagnostic and treatment purposes is trending, emphasizing the potential of AI to enhance clinical decision-making and patient outcomes.
  3. Patient-Centered Care Models:
    Emerging themes are increasingly centered around patient preferences, shared decision-making, and the incorporation of patient-reported outcomes into health technology assessments.
  4. Complex Interventions for Multimorbidity:
    A growing body of literature addresses complex interventions designed for populations with multimorbidity, highlighting the need for tailored approaches to improve health outcomes.
  5. Sustainability and Health Economics:
    Studies assessing the sustainability of health technologies and their long-term economic impact are gaining traction, reflecting a broader recognition of environmental and economic factors in healthcare.

Declining or Waning

While 'Health Technology Assessment' continues to advance in various domains, certain research themes appear to be waning in prominence. This section highlights these declining trends based on recent publications.
  1. Traditional Pharmacological Studies:
    Research focused solely on traditional pharmacological interventions without considering broader health technology assessments seems to be less frequent, indicating a shift towards more integrated approaches.
  2. Single-Domain Evaluations:
    There is a noticeable decline in studies that evaluate health technologies from a single perspective (e.g., only clinical or only economic), with a growing preference for multi-faceted evaluations.
  3. Narrowly Defined Patient Populations:
    Research targeting very specific patient populations without broader applicability has decreased, as there's a move towards studies that encompass diverse populations and conditions.
  4. Basic Clinical Trials:
    Standard clinical trials without an accompanying health technology assessment or economic evaluation are becoming less common, reflecting a trend towards incorporating comprehensive evaluations.

Similar Journals

MDM Policy & Practice

Fostering Collaborative Solutions for Health Challenges
Publisher: SAGE PUBLICATIONS INCISSN: Frequency: 1 issue/year

MDM Policy & Practice is a premier open-access journal published by SAGE Publications Inc, focusing on the critical fields of Health Policy and Public Health, Environmental and Occupational Health. Since its inception in 2016, this journal has aimed to provide an authoritative platform for disseminating research findings, policy discussions, and innovative practices that drive improvements in health systems globally. With an impact factor that reflects its growing influence in the academic landscape, it holds a Q2 ranking in both Health Policy and Public Health categories as of 2023. This journal leverages its accessibility to foster a collaborative environment for researchers, policymakers, and practitioners alike, encouraging the exchange of ideas and knowledge to address pressing health challenges. Operating under a commitment to open access, MDM Policy & Practice ensures that vital research is available to a wider audience, fostering informed decision-making and progressive advancements in the health policy sphere.

VALUE IN HEALTH

Exploring the Intersection of Health Policy and Practice
Publisher: ELSEVIER SCIENCE INCISSN: 1098-3015Frequency: 12 issues/year

VALUE IN HEALTH, published by Elsevier Science Inc, is a premier peer-reviewed journal in the fields of Health Policy, Medicine, and Public Health. With an impressive impact factor reflecting its respected standing, the journal has achieved a distinguished Q1 classification in multiple categories, placing it among the top publications in the health domain. Since its inception in 1998, this journal has been a vital platform for disseminating research that informs health policy and practice, impacting both clinical and public health decision-making. The journal’s Scopus rankings further underscore its global influence, with notable positions in Medicine and Public Health sectors. VALUE IN HEALTH is committed to fostering an environment where innovative research meets practical application, ultimately aiming to enhance health outcomes worldwide. Researchers, professionals, and students alike are encouraged to explore the wealth of knowledge contained within its pages.

Health Policy and Technology

Empowering change in health systems with technological solutions.
Publisher: ELSEVIER SCI LTDISSN: 2211-8837Frequency: 4 issues/year

Health Policy and Technology is a prestigious academic journal published by ELSEVIER SCI LTD that has established itself as a leader in the fields of Biomedical Engineering and Health Policy. With an impressive Q1 ranking in both disciplines as of 2023, the journal offers a platform for original research, reviews, and innovative technological solutions that aim to bridge the gap between health policy and technology. Since its inception in 2012, it has served as a vital resource for researchers, professionals, and students who are seeking to explore the impact of technology on healthcare systems and policies globally. Although it is not an open-access journal, the high-quality, peer-reviewed articles published within its pages contribute significantly to the discourse on the advancement of healthcare practices. The journal's commitment to disseminating groundbreaking studies ensures it remains a crucial reference point in these rapidly evolving fields.

Journal of Comparative Effectiveness Research

Advancing health policy with rigorous evaluation.
Publisher: Becaris PublishingISSN: 2042-6305Frequency: 18 issues/year

Journal of Comparative Effectiveness Research is a leading academic journal dedicated to the evaluation of healthcare interventions and practices, published by Becaris Publishing. Since transitioning to a fully Open Access model in 2023, the journal has expanded its accessibility to a global audience of researchers, healthcare professionals, and policy makers. With a focus on comparative effectiveness in health policy, it has achieved a notable ranking of #132 out of 310 in the Scopus category for Medicine and Health Policy, placing it in the 57th percentile for scholarly impact. Operating from the United Kingdom, the journal encompasses research from 2012 to 2024 and firmly establishes itself in the academic landscape as a Q2 journal in the Health Policy category as of 2023. By disseminating high-quality, evidence-based research, the Journal of Comparative Effectiveness Research plays a vital role in informing clinical practice and health policy decision-making, making it an essential resource for those dedicated to improving health outcomes.

Cost Effectiveness and Resource Allocation

Fostering Global Dialogue on Cost-Effectiveness Strategies
Publisher: BMCISSN: 1478-7547Frequency: 1 issue/year

Cost Effectiveness and Resource Allocation is a premier open-access journal published by BMC, dedicated to advancing the field of health policy and economics. Since its inception in 2003, the journal has provided a platform for researchers, policymakers, and healthcare professionals to disseminate crucial findings and insights relevant to cost-effectiveness analyses and resource allocation strategies. With an increasing impact factor and ranking within the Q2 category of health policy journals, it ranks #138 out of 310 in Scopus, placing it in the 55th percentile among its peers. The journal aims to facilitate knowledge exchange that can transform health policy and improve healthcare delivery through rigorous research, evaluation, and dialogue. Open access since its establishment, it ensures that critical findings are available to a global audience, thereby enhancing the impact and reach of its published works.

Applied Health Economics and Health Policy

Innovating health solutions through economic evaluation.
Publisher: SPRINGER INT PUBL AGISSN: 1175-5652Frequency: 6 issues/year

Applied Health Economics and Health Policy, published by Springer International Publishing AG, stands as a premier academic journal dedicated to the intersection of economic theory and health policy. With a strong focus on the practical application of economic principles to health issues, this journal addresses crucial topics such as healthcare financing, resource allocation, and economic evaluation of health interventions. Its impressive rankings—in the top quartile for both Health Policy and Medicine, as well as a notable second quartile in Economics—illustrate its significant impact within the fields of health economics and policy research. The journal is aimed at researchers, policymakers, and students who seek to explore innovative solutions to contemporary health challenges. Established in 2002 with ongoing publications through 2024, the journal features open access options that enhance accessibility and engagement with its extensive body of research articles, ensuring that vital insights are available to a global audience.

Expert Review of Pharmacoeconomics & Outcomes Research

Elevating Standards in Pharmacoeconomic Research
Publisher: TAYLOR & FRANCIS LTDISSN: 1473-7167Frequency: 6 issues/year

Expert Review of Pharmacoeconomics & Outcomes Research is a leading journal published by TAYLOR & FRANCIS LTD, focusing on the critical intersection of pharmacoeconomics and healthcare outcomes. Established in 2001, the journal has been a key resource for researchers and professionals in the fields of health policy, medicine, and pharmacology, consistently ranked in the top quartile of these categories for its influential insights. With an ISSN of 1473-7167 and an E-ISSN of 1744-8379, it delivers cutting-edge research that informs healthcare decisions and policy frameworks. The journal's rigorous peer-review process ensures the publication of high-quality, impactful articles that address contemporary challenges and advancements in pharmacoeconomic evaluations. As of 2023, it boasts a commendable ranking of #106 in Health Policy and #124 in Pharmacology, affirming its relevance and contribution to the field. Despite being a subscription-based journal, the strength of its content makes it an invaluable tool for researchers and practitioners aiming to enhance patient outcomes and optimize resource allocation in healthcare systems.

JOURNAL OF TELEMEDICINE AND TELECARE

Shaping the future of healthcare through rigorous research.
Publisher: SAGE PUBLICATIONS LTDISSN: 1357-633XFrequency: 10 issues/year

JOURNAL OF TELEMEDICINE AND TELECARE, published by SAGE PUBLICATIONS LTD, stands at the forefront of the rapidly evolving fields of health informatics and telemedicine. With its ISSN 1357-633X and E-ISSN 1758-1109, this prestigious journal has been a vital platform for innovation and research since its inception in 1995, covering a wide array of topics from remote patient monitoring to the integration of artificial intelligence in healthcare delivery. Recognized for its rigorous academic standards, the journal boasts an impressive impact factor, positioning it in the Q1 quartile for Health Informatics and securing a remarkable rank of #9 out of 138 in Scopus, placing it in the 93rd percentile among its peers. By disseminating high-quality research, the JOURNAL OF TELEMEDICINE AND TELECARE contributes significantly to the advancement of knowledge, shaping best practices in telehealth and enhancing patient care worldwide. As a non-open access journal, it appeals to a broad audience of researchers, healthcare professionals, and students, facilitating critical discourse on the future of healthcare technology. Stay at the forefront of this essential domain by engaging with the latest findings and projects featured in this influential publication.

BMJ Surgery Interventions & Health Technologies

Advancing surgical interventions with cutting-edge insights.
Publisher: BMJ PUBLISHING GROUPISSN: Frequency: 1 issue/year

BMJ Surgery Interventions & Health Technologies, published by the BMJ Publishing Group, is a pioneering open access journal established in 2019 that focuses on groundbreaking research in the realms of surgery and biomedical engineering. As an essential resource for researchers, professionals, and students, this journal strives to advance the understanding of surgical interventions and the technologies that support them. With a commendable Q2 ranking in Surgery and a Q3 ranking in Biomedical Engineering, the journal has quickly positioned itself as a vital contributor to the literature in these fields, ranking #211 out of 551 in Medicine Surgery and #203 out of 303 in Biomedical Engineering according to Scopus. The committed editorial team seeks to foster innovative discussions and disseminate cutting-edge findings that address the evolving challenges faced in surgical practices. By offering open access publication since its inception, it ensures that high-quality research is freely available to a global audience, fostering collaborative advancements in health technologies and surgical outcomes.

Pharmacoeconomics-Open

Unlocking Insights for a Healthier Tomorrow
Publisher: SPRINGER INT PUBL AGISSN: 2509-4262Frequency: 4 issues/year

Pharmacoeconomics-Open, an esteemed journal published by SPRINGER INT PUBL AG, is a vital resource for scholars and practitioners in the fields of health policy and pharmacology. Since its transition to an Open Access platform in 2017, the journal has aimed to democratize access to valuable research, fostering innovation and collaboration globally. With notable rankings in the 2023 Scopus indices—including Q2 in Health Policy and both categories of Pharmacology—Pharmacoeconomics-Open engages with pressing issues in health economics, providing insights into cost-effectiveness analyses and healthcare decision-making. The journal’s commitment to high-quality, peer-reviewed articles ensures that it remains a significant player in advancing knowledge and understanding within its disciplines, serving as an essential forum for researchers, policymakers, and students alike.